Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Scientist.com to Connect with Local Pharma Thought Leaders at BIOJapan


Scientist.com, the pharmaceutical industry's largest online marketplace for outsourced research, today announced that it will be attending BIOJapan from October 9 ? 11, 2019 in Yokohama, Japan. The Scientist.com marketplace is helping Japanese research companies standardize and simplify their R&D outsourcing - saving time, reducing costs and ensuring adherence to internal and external policies and regulations.

The online marketplace serves as a regularly updated source of newly commercialized tools and technologies from around the world.

"BIOJapan presents a unique opportunity for Scientist.com to discuss partnerships with research organizations from the Asia-Pacific region and to meet face-to-face with our existing clients in Japan to strengthen those relationships," said Mark Herbert, Chief Business Officer of Scientist.com. "Scientist.com's award-winning marketplace helps Japanese pharma companies standardize and simplify their R&D outsourcing - saving time and money and providing easy access to the most innovative life science technologies."

Scientist.com currently operates private outsourcing marketplaces for 4 of the top 5 Japanese pharmaceutical companies, including Takeda. In 2018, Scientist.com created Scientist.com GK, a wholly-owned Japan-based subsidiary. The company's Japanese office is located in the Nihonbashi Life Sciences building in Tokyo.

Please join the Scientist.com team at BIOJapan at exhibit booth B-1 in the Biocom-California Pavilion.

About Scientist.com

Scientist.com is the world's leading enterprise gateway marketplace for outsourced R&D. The marketplace simplifies research sourcing, saving time and money, reducing risk and providing access to the latest innovative tools and technologies. Scientist.com operates private enterprise marketplaces for most of the world's major pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $32 million from 5AM Ventures, Leerink Transformation Partners and Heritage Provider Network among others. Visit scientist.com to learn more.

Join Scientist.com on social media: LinkedIn, Twitter, YouTube, Facebook and Instagram.


These press releases may also interest you

at 17:50
Amphivena Therapeutics, Inc., a private clinical stage immuno-oncology company developing T cell engager therapeutics for cancer, presented today at the American Society of Hematology annual meeting data from a Phase 1 study of its bivalent T cell...

at 17:40
Welltower Inc. announces that on December 24, 2019, it is redeeming all of the outstanding 3.35% Senior Notes due November 25, 2020 (the "Notes") issued by HCN Canadian Holdings-1 LP, its wholly-owned subsidiary, in accordance with the terms of the...

at 17:20
Quest Diagnostics Incorporated , the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $800 million aggregate principal amount of its 2.950% senior notes due 2030 under the Quest...

at 17:20
Bariatric Surgery Devices (General Surgery) - Global Market Analysis and Forecast Model Read the full report: https://www.reportlinker.com/p05830908/?utm_source=PRN Summary Bariatric Surgery Devices (General Surgery) - Global Market Analysis and...

at 17:19
Florida International University Distinguished Professor Madhavan Nair has been named a Fellow of the National Academy of Inventors (NAI). Nair, an internationally renowned expert in nanotechnology and HIV research, is the founding chair of the...

at 17:05
TFF Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced its third quarter 2019...



News published on 4 october 2019 at 19:35 and distributed by: